Table 3.

Odds of Tanner stage >1 or TV >3 ml associated with an IQR increase in trimester-specific, SG-corrected in utero urinary phthalate metabolite or BPA concentration^a

	Visit 1 (n = 90)	Visit 2 (n = 89)	Visit 3 (n = 105)	Prenatal GM (n = 106)
	OR/IQR (95% CI)	OR/IQR (95% CI)	OR/IQR (95% CI)	OR/IQR (95% CI)
Genital Development
BPA	0.71 (0.39, 1.28)	1.41 (0.78, 2.54)	0.93 (0.53, 1.61)	1.04 (0.5, 2.14)
MBzP	0.95 (0.58, 1.55)	0.98 (0.57, 1.68)	0.71 (0.37, 1.36)	0.75 (0.37, 1.51)
MCPP	1.2 (0.61, 2.36)	1.16 (0.53, 2.54)	0.97 (0.53, 1.77)	1.14 (0.48, 2.73)
MEP	1.5 (0.79, 2.85)	1.17 (0.56, 2.48)	1.09 (0.58, 2.03)	1.27 (0.58, 2.81)
ΣDEHP	0.99 (0.56, 1.74)	0.85 (0.46, 1.57)	0.71 (0.4, 1.29)	0.77 (0.37, 1.62)
ΣDBP	0.77 (0.47, 1.27)	0.86 (0.48, 1.52)	0.59 (0.31, 1.13)	0.57 (0.27, 1.21)
Pubic Hair
BPA	0.2 (0.02, 2.76)	1.1 (0.31, 3.9)	0.42 (0.13, 1.36)	0.72 (0.19, 2.73)
MBzP	0.13 (0.01, 1.56)	0.99 (0.26, 3.73)	0.18 (0.03, 0.97)*	0.31 (0.1, 0.93)*
MCPP	0.33 (0.02, 4.72)	5.99 (0.5, 72.02)	0.47 (0.16, 1.37)	0.5 (0.11, 2.26)
MEP	2.04 (0.36, 11.58)	1.31 (0.22, 7.85)	0.44 (0.15, 1.24)	0.52 (0.17, 1.6)
ΣDEHP	0 (0, 542.1)	2.22 (0.28, 17.34)	0.27 (0.07, 0.99)*	0.16 (0.03, 1.02)
ΣDBP	0.28 (0.02, 3.85)	2.68 (0.48, 15.08)	0.36 (0.13, 1.06)	0.39 (0.11, 1.42)
Testicular Volume
BPA	1.28 (0.67, 2.45)	2.01 (0.94, 4.28)	1.34 (0.68, 2.66)	2.29 (0.87, 5.98)
MBzP	0.7 (0.39, 1.23)	0.62 (0.3, 1.29)	0.73 (0.33, 1.6)	0.4 (0.16, 1)*
MCPP	0.56 (0.25, 1.27)	1.59 (0.6, 4.23)	1.03 (0.5, 2.12)	1.07 (0.36, 3.19)
MEP	1.33 (0.64, 2.76)	0.75 (0.31, 1.86)	1.32 (0.6, 2.91)	1.16 (0.44, 3.06)
ΣDEHP	1.21 (0.64, 2.3)	0.99 (0.49, 2)	1.5 (0.75, 3)	1.94 (0.7, 5.34)
ΣDBP	1 (0.54, 1.84)	1.66 (0.85, 3.25)	0.88 (0.44, 1.75)	1.35 (0.54, 3.4)

*p < 0.05

^aAdjusted for child age and BMI z-score